4D Molecular Therapeutics SG&A Expense (TTM) Analysis

4D Molecular Therapeutics Inc (FDMT)

9.98 -0.36 (-3.48%) USD | NASDAQ | Oct 04, 16:00

9.98 0.00 (0.00%) After-Hours: 19:19

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	40.61M
March 31, 2024	38.80M
December 31, 2023	36.50M
September 30, 2023	34.36M
June 30, 2023	33.30M
March 31, 2023	32.68M
December 31, 2022	32.92M
September 30, 2022	31.78M
June 30, 2022	31.91M

Date	Value
March 31, 2022	30.70M
December 31, 2021	28.01M
September 30, 2021	27.52M
June 30, 2021	23.02M
March 31, 2021	19.13M
December 31, 2020	17.24M
September 30, 2020	16.36M
June 30, 2020	15.73M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

15.73M

Minimum

Jun 2020

40.61M

Maximum

Jun 2024

28.86M

Average

31.78M

Median

Sep 2022

SG&A Expense (TTM) Benchmarks